| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antibodies and other biomarkers – pathological consequences (2)
|
Ehrenstein, MR
|
|
2008
|
17 |
3 |
p. 256-258
|
artikel
|
| 2 |
Antiphospholipid antibodies induce vascular functional changes in mice: a mechanism of vascular lesions in antiphospholipid syndrome?
|
Belizna, C
|
|
2008
|
17 |
3 |
p. 185-194
|
artikel
|
| 3 |
Autoantibodies and other biomarkers – pathological consequences (1)
|
Giles, I
|
|
2008
|
17 |
3 |
p. 241-246
|
artikel
|
| 4 |
Cellular interactions and signalling defects in lupus (1)
|
Zouali, M
|
|
2008
|
17 |
3 |
p. 236-240
|
artikel
|
| 5 |
E/E' ratio is more sensitive than E/A ratio for detection of left ventricular diastolic dysfunction in systemic lupus erythematosus
|
Lee, S-W
|
|
2008
|
17 |
3 |
p. 195-201
|
artikel
|
| 6 |
High concomitance of disease marker autoantibodies in anti-DFS70/LEDGF autoantibody–positive patients with autoimmune rheumatic disease
|
Muro, Y
|
|
2008
|
17 |
3 |
p. 171-176
|
artikel
|
| 7 |
Hypothyroidism determines the clinical and immunological manifestations of Arabs with lupus
|
Al Saleh, J
|
|
2008
|
17 |
3 |
p. 215-220
|
artikel
|
| 8 |
Introduction to a systemic lupus erythematosus – biomarkers meeting held at University College London on 23rd and 24th February 2007
|
Isenberg, David
|
|
2008
|
17 |
3 |
p. 231-231
|
artikel
|
| 9 |
Lupus: improving long-term prognosis
|
Doria, A
|
|
2008
|
17 |
3 |
p. 166-170
|
artikel
|
| 10 |
Origin and structure of autoantibodies and antigens in autoimmune rheumatic diseases
|
Rahman, A
|
|
2008
|
17 |
3 |
p. 232-235
|
artikel
|
| 11 |
Pathogenic factors for the development of lupus nephritis
|
Mason, LJ
|
|
2008
|
17 |
3 |
p. 251-255
|
artikel
|
| 12 |
Severe digital ischemia–a presenting symptom of malignancy–associated antiphospholipid syndrome
|
Grossman, A
|
|
2008
|
17 |
3 |
p. 206-209
|
artikel
|
| 13 |
Signalling defects and cellular interactions (2)
|
Datta, SK
|
|
2008
|
17 |
3 |
p. 247-250
|
artikel
|
| 14 |
Successful treatment of amegakaryocytic thrombocytopenia with anti-CD20 antibody (rituximab) in a patient with systemic lupus erythematosus
|
Fukushima, T
|
|
2008
|
17 |
3 |
p. 210-214
|
artikel
|
| 15 |
Successful use of rituximab in acquired C1 inhibitor deficiency secondary to Sjögren’s syndrome
|
Sánchez-Cano, D
|
|
2008
|
17 |
3 |
p. 228-229
|
artikel
|
| 16 |
Sulpha allergy in lupus patients: a clinical perspective
|
Jeffries, M
|
|
2008
|
17 |
3 |
p. 202-205
|
artikel
|
| 17 |
Systemic lupus erythematosus in the Fars Province of Iran
|
Nazarinia, MA
|
|
2008
|
17 |
3 |
p. 221-227
|
artikel
|
| 18 |
Therapeutic potential (2)
|
Silverman, GJ
|
|
2008
|
17 |
3 |
p. 262-265
|
artikel
|
| 19 |
Therapeutic potential (1)
|
Zack, Debra Jeske
|
|
2008
|
17 |
3 |
p. 259-261
|
artikel
|
| 20 |
Time to seizure occurrence and damage in PROFILE, a multi-ethnic systemic lupus erythematosus cohort
|
Ramsey-Goldman, R
|
|
2008
|
17 |
3 |
p. 177-184
|
artikel
|
| 21 |
Viruses and lupus: the viral hypothesis
|
Ramos-Casals, Manel
|
|
2008
|
17 |
3 |
p. 163-165
|
artikel
|
Tijdschrift beschrijving